Page last updated: 2024-12-04

1,2-didecanoylglycerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

## 1,2-Didecanoylglycerol (DDGly) and its Importance in Research

1,2-Didecanoylglycerol (DDGly) is a **monoacylglycerol** with two decanoic acid (capric acid) molecules attached to the glycerol backbone. This makes it a **saturated** and **short-chain** monoacylglycerol, with a relatively simple structure.

**Why is DDGly important for research?**

* **Potent agonist of GPR119:** DDGly is a potent agonist of the **G protein-coupled receptor 119 (GPR119)**. GPR119 is expressed mainly in the **pancreas** and **intestine** and plays a significant role in regulating **glucose homeostasis** and **insulin secretion**.
* **Glucose Metabolism:** Activation of GPR119 by DDGly can lead to **increased insulin secretion**, **reduced glucagon secretion**, and **improved glucose tolerance**. This makes it a promising target for the treatment of **type 2 diabetes**.
* **Lipid Metabolism:** GPR119 activation can also **reduce appetite** and **promote lipid metabolism**.

* **Preclinical studies:** DDGly has shown promising results in **preclinical studies** for the treatment of type 2 diabetes and other metabolic disorders.
* **Animal models:** Studies on animal models have demonstrated that DDGly can **improve glucose tolerance**, **reduce insulin resistance**, and **lower blood glucose levels**.
* **Obesity:** In obese animal models, DDGly has shown to **reduce body weight** and **improve lipid profiles**.

* **Drug development:** DDGly's potent activity at GPR119 has sparked the development of **new drugs** targeting this receptor. Several **small molecule agonists** of GPR119 are currently in clinical trials, with the goal of treating type 2 diabetes and other metabolic disorders.

**Beyond Diabetes:**

While the focus is on diabetes, DDGly's interaction with GPR119 could also be explored for other applications:

* **Anti-inflammatory effects:** GPR119 activation has been linked to **anti-inflammatory effects** in some studies.
* **Gastrointestinal health:** GPR119 is expressed in the gastrointestinal tract, suggesting potential roles in **regulating gut motility** and **intestinal inflammation**.

**Overall, DDGly is a valuable research tool due to its potent activation of GPR119 and its promising therapeutic potential. Further research into its mechanisms of action and clinical applications is ongoing.**

1,2-didecanoylglycerol: functions as bioregulator of protein kinase C in human platelets; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1321
CHEMBL ID1871790
CHEBI ID11152
SCHEMBL ID611847
MeSH IDM0129511

Synonyms (61)

Synonym
CBIOL_001866
BIO2_000489
BIO1_000641
BIO2_000009
BIO1_001130
BIO1_000152
IDI1_033759
BSPBIO_001289
bdbm20717
(1-decanoyloxy-3-hydroxypropan-2-yl) decanoate
didecanoyl glycerol
1-(decanoyloxy)-3-hydroxypropan-2-yl decanoate
1,2-didecanoylglycerol
NCGC00161331-01
NCGC00161331-02
KBIO2_002577
KBIOGR_000009
KBIOSS_000009
KBIO3_000018
KBIO2_005145
KBIO2_000009
KBIO3_000017
NCGC00161331-03
CHEBI:11152 ,
3-hydroxypropane-1,2-diyl didecanoate
1,2-dicaprin
17863-69-3
HMS1989A11
82950-64-9
1,2-didecanoyl-glycerol (10:0)
BML2-F05
HMS1361A11
HMS1791A11
(2-decanoyloxy-3-hydroxypropyl) decanoate
decanoic acid, 1-(hydroxymethyl)-1,2-ethanediyl ester
FT-0641890
SCHEMBL611847
D5K11SW7QP
glyceryl-1,2-dicaprate
glyceryl 1,2-dicaprate
1,2-dicapryl-sn-glycerol
1,2-didecanoyl-rac-glycerol
3-hydroxypropane-1,2-diyl bis(decanoate)
capric diglyceride
GNSDEDOVXZDMKM-UHFFFAOYSA-N
glycerol 1,2-didecanoate
decanoin, 1,2-di-
1,2-rac-dicaprin
CHEMBL1871790
HMS3402A11
(2-hexanoyloxy-3-hydroxy-propyl)hexanoate
AKOS027383852
CS-0255615
FT-0770496
DTXSID60939105
Q27108688
HY-115769
PD050134
(+/-) 1,2-didecanoylglycerol (10:0)
decanoic acid, 1,1'-[1-(hydroxymethyl)-1,2-ethanediyl] ester
dg 10:0_10:0

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" sn-1,2-Didecanoylglycerol was evaluated as a complete skin tumor promoter in CD-1 mice utilizing a dosing regimen demonstrated to produce epidermal hyperplasia."( Synthetic lipid second messenger sn-1,2-didecanoylglycerol: a complete tumor promoter in mouse skin.
Conney, AH; Hansen, LA; Mills, KJ; Smart, RC, 1989
)
1.11
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
1,2-diglyceride
decanoate esterA fatty acid ester resulting from the formal condensation of the carboxy group of decanoic acid (capric acid) with the hydroxy group of an alcohol or phenol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
regulator of G-protein signaling 4Homo sapiens (human)Potency26.67950.531815.435837.6858AID504845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (36.11)18.7374
1990's13 (36.11)18.2507
2000's4 (11.11)29.6817
2010's4 (11.11)24.3611
2020's2 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]